登录 | 注册    关注公众号  
微信公众号
搜索
 >  Cell>EGF R >CHEK-ATF049

EGFR (Luc) HEK293 Reporter Cell

For research use only.

描述(Description)

The Human EGF R (Luc) HEK293 Reporter Cell was engineered to not only express STAT3 signaling response element, but also express the receptor full length human EGF R (Gene ID: 1956). When stimulated with human EGF protein, the EGF/EGF R interaction drives STAT3-mediated luminescence. Inhibition of EGF binding to EGF R by either anti-EGF or anti-EGF R antibodies results in a decrease in luminescence.

应用说明(Application)

1. Screen for anti-human EGF R or anti-human EGF neutralizing antibody.

2. Screen for human EGF R small molecule inhibitor

EGF R Assay Principles

生长特性(Growth Properties)

Adherent

筛选标记(Selection Marker)

Hygromycin (40 μg/mL) + Puromycin (2 μg/mL)

培养基(Culture Medium)

DMEM medium + 10% FBS

冻存液(Freeze Medium)

Serum-free cell cryopreservation medium

装量(Quantity)

1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

存储(Storage)

Frozen in liquid nitrogen.

支原体检测(Mycoplasma Testing)

Negative

无菌检测(Sterility Testing)

Negative

使用说明(Instructions for Use)

See data sheet for detailed culturing and assay protocol.

 

Receptor Assay

EGF R FACS

Expression analysis of human EGF R on Human EGF R (Luc) HEK293 Reporter Cell by FACS.
Cell surface staining was performed on Human EGF R (Luc) HEK293 Reporter Cell or negative control cell using PE-labeled anti-EGF R antibody.

Protocol

 

Application

EGF R APPLICATION

Inhibition of human EGF protein-induced reporter activity by anti-human EGF R neutralizing antibody.
This reporter cell was incubated with serial dilutions of antibodies in the presence of human EGF protein (Cat. No. EGF-H52H3) with a final concentration of 50 ng/mL. The EC50 of anti-human EGF R neutralizing antibody (Cetuximab) is approximately 1.793 μg/mL.

Protocol

EGF R APPLICATION

Inhibition of human EGF protein-induced reporter activity by human EGF R small molecule inhibitor.
This reporter cell was incubated with serial dilutions of inhibitors in the presence of human EGF protein (Cat. No. EGF-H52H3) with a final concentration of 50 ng/mL. The EC50 of human EGF R small molecule inhibitor (Erlotinib) was approximately 0.01 μM.

Protocol

 

Signaling Bioassay

EGF R SIGNALING

Response to human EGF protein (RLU).
The Human EGF R (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human EGF protein (Cat. No. EGF-H52H3). The EC50 was approximately 56.23 ng/mL.

Protocol

EGF R SIGNALING

Response to human EGF protein (Fold).
The Human EGF R (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human EGF protein (Cat. No. EGF-H52H3). The max induction fold was approximately 56.

Protocol

 

Passage Stability

EGF R PASSAGE

Passage stability analysis by Signaling Bioassay.
The continuously growing Human EGF R (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human EGF protein. Human EGF protein stimulated response demonstrates passage stabilization (fold induction and EC50) across passage 10-20.

Protocol

如有相关细胞池需求请联系我们

 

背景(Background)

The epidermal growth factor receptor (EGFR) belongs to the ErbB family of receptor tyrosine kinases (RTK). The aberrant activity of EGFR has shown to play a key role in the development and growth of tumor cells, where it is involved in numerous cellular responses including proliferation and apoptosis.

 

Permits & Restrictions

This cell line is provided for research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use. You are not allowed to share, distribute, sell, modify, sublicense, or otherwise make this cell line available for use to other laboratories, departments, research institutions, hospitals, universities, or biotech companies. AcroBiosystems does not warrant the suitability of this cell line for any particular use, and does not accept any liability in connection with the handling or use of this cell line.

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
EGF R靶点信息
英文全称:Epidermal growth factor receptor erbB1
中文全称:表皮生长因子受体erbB1
种类:Homo sapiens
上市药物数量:31详情
临床药物数量:169详情
最高研发阶段:批准上市
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定